Delivery Order SPE2DB24D1104-SPE2DB24FYCP1
Award Date
9/6/24
Potential Completion Date
9/27/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,030.77 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of March 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
The federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency. The fixed-price, $2,343.59 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 9, 2025 with a completion date of July 30, 2025. The contract is not set aside and represents an individual delivery order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,030.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of January 2, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $4,687.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $4,530.60 fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024. The contract has an ultimate completion date of July 29, 2024 and was not set aside for a specific business type. Amerisourcebergen holds a single-award Indefinite Delivery...
This federal contract award is a Delivery Order for TEZSPIRE 210 MG/1.91 ML PEN 1.91ML with a ceiling value of $2,265.29. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 7, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML medical supplies, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $4,687.18 firm fixed-price contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This federal contract award, issued by the Defense Logistics Agency (DLA), provides for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The $4,530.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The award has an ultimate completion date of June 26, 2024 and is not associated with any set-aside requirements. This delivery order is part of AmerisourceBergen's broader...
The federal contract award summarized is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024 with a ceiling value of $2,343.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 10, 2025. There was no set-aside designation for this...
This federal contract award is for the provision of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 26, 2024. The contract is a Delivery Order with a Firm Fixed Price of $4,687.18 and an ultimate completion date of December 18, 2024. This award is associated with a larger Indefinite...